There are no new cases of COVID-19 to report in South East Zone 4, which includes Estevan, according to the daily report for June 10.
There were also four recoveries in Zone 4, leaving the total number of active cases for Zone 4 at 11.
There are seven new cases on the rest of South East region, all located in South East Zone 2 north of Zone 4.
There are 77 new cases of COVID-19 to report in Saskatchewan, along with 129 recoveries and one new death. Saskatchewan has now had 47,668 cases of COVID-19.
The other new cases in Saskatchewan are located in the following zones: Far North West, 9; Far North East, 1; North West, 8; North Central, 10; Saskatoon, 18; Central East, 1; Regina, 8; South West, 2; and South Central, 12.
Eighteen cases who tested out of province were added: North Central, 1; Saskatoon, 7; Central West, 1; Regina, 8; and one case with pending resident information. One case in the South Central zone was found not to be a Saskatchewan resident and removed from case counts.
One new death is being reported today in the 70 to 79 age group in the Central East zone.
A total of 553 people in Saskatchewan with COVID-19 have died.
Recoveries total 46,213. Nine of the new recoveries are from the South East region.
A total of 902 cases are considered active, including 47 from the South East.
There are 101 people in hospital, including one receiving in-patient care in the southeast. Eighty-two people are receiving inpatient care in Saskatchewan, including one out of province transfer from Manitoba, and 19 are in intensive care.
The seven-day average of new COVID-19 case number is 79 (6.4 per 100,000).
There were 2,503 COVID-19 tests processed in Saskatchewan on June 9, including 93 from the South East.
An additional 16,787 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 845,439. The South East accounted for 1,219 of the new doses.
Seventy-eight per cent of those over the age of 40 have received their first dose. Seventy-three per cent of those 30+ have received their first dose. Sixty-eight per cent of those 18+ have received their first dose, while sixty-six per cent of those 12+ have also received their first dose.
